Efficacy of a Health Education and Self-Awareness Booklet with Specific Therapeutic Exercises versus Vitamin D3 Supplementation for Managing Chronic Low Back Pain: An Assessor-Blinded, Multicentre Randomised Clinical Trial
1Department of Nutrition & Food Technology, Faculty of Applied Science and Technology, Jashore University of Science & Technology, Jashore 7408, Bangladesh.
2Department of Physiotherapy, Saic College of Medical Science and Technology, Mirpur-14, Dhaka-1216, Bangladesh.
3Executive Director, Centre for the Rehabilitation of the Paralysed (CRP), Savar, Dhaka-1343, Bangladesh.
4Department of Physiotherapy & Rehabilitation, Faculty of Health Science, Jashore University of Science & Technology, Jashore, 7408, Bangladesh.
5Department of Physiotherapy, Mymensingh College of Physiotherapy and Health Sciences, Mymensingh-2200, Bangladesh.
6Central Queensland Public Health Unit, Central Queensland Hospital and Health Service, Rockhampton, Queensland, 4700, Australia.
7School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton, Queensland, 4701, Australia.
Received 9 August 2025 • Accepted 8 September 2025 • Published online 12 March 2026
Abstract:
Objective: Maintaining optimal vitamin D3 levels may play a key role in managing chronic low back pain (CLBP) and enhancing functional outcomes. This study aimed to compare the effects of health education and self-awareness booklets versus vitamin D3 supplementation combined with therapeutic exercises on pain intensity, vitamin D levels, and functional disability in individuals with CLBP.
Material and Methods: This randomized clinical trial was conducted at two physiotherapy rehabilitation centers in Dhaka, Bangladesh, involving 84 participants with chronic low back pain (CLBP), randomly allocated into two equal groups. Group A received specific therapeutic exercises and a health education/self-awareness booklet, while Group B received vitamin D3 supplementation alongside the same exercises over a three-month period. Primary outcomes included pain intensity (assessed via the Brief Pain Inventory) and serum vitamin D3 levels. Functional disability, measured using the Roland-Morris Disability Questionnaire (RMDQ), served as the secondary outcome. Assessments were conducted at baseline and post-intervention, with a per-protocol analysis applied.
Results: Both groups demonstrated significant improvements in pain intensity and functional disability following the intervention (p-value<0.001). However, Group B showed significantly greater reductions in disability scores (p-value<0.001), which corresponded with a marked increase in serum vitamin D3 levels (p-value<0.001).
Conclusion: Both interventions were effective in reducing pain and disability in individuals with CLBP. However, the addition of vitamin D3 supplementation led to significantly greater improvements, highlighting its potential role in enhancing the efficacy of conservative CLBP management.
Keywords: chronic low back pain, health education booklet, therapeutic exercise, vitamin D3 supplementation
Department of Nutrition & Food Technology, Faculty of Applied Science and Technology,
Jashore University of Science & Technology, Jashore 7408, Bangladesh.
E-mail: ashraf@just.edu.bd
doi: 10.31584/jhsmr.20261328
www.jhsmr.org
© 2026 JHSMR. Hosted by Prince of Songkla University. This is an open access article under the CC BY-NC-ND license (http://www.jhsmr.org/index.php/jhsmr/about/editorialPolicies#openAccessPolicy).
Introduction
Vitamin D3 is essential for maintaining musculoskeletal health, particularly in supporting bone integrity and skeletal muscle function in the lower back region1. It is predominantly synthesized through sunlight exposure, with its active form, 1,25-dihydroxyvitamin D3 (calcitriol), exerting effects via vitamin D3 receptors (VDRs) in various tissues2. These receptors influence cell growth, differentiation, and neuromuscular function. Deficiency in vitamin D3 can impair muscle performance and contribute to chronic pain through mechanisms such as oxidative stress, mitochondrial dysfunction, and central neuronal hypersensitivity3.
Vitamin D deficiency—commonly defined as serum 25-hydroxyvitamin D3 levels below 20 ng/mL (50 nmol/L)— is a widespread public health concern, even in sun-rich countries4. Prevalence estimates range from 37–42% in temperate zones (e.g., the US and Europe) to 22–33% in tropical regions like Thailand and Singapore5. Contributing factors include limited sun exposure, inadequate dietary intake, obesity, darker skin pigmentation, and comorbid conditions such as diabetes mellitus6.
Chronic low back pain (CLBP) is a highly prevalent condition with multifactorial origins and complex management needs. Current best practices recommend a multidisciplinary approach combining physical, educational, and, when appropriate, biochemical interventions7. Therapeutic exercises are central to CLBP management, addressing core strength, flexibility, and neuromotor control. Exercises such as planks, bridges, and stretches reduce mechanical strain, improve movement patterns, and help alleviate pain and prevent recurrence8.
Complementing physical interventions, health education and self-awareness booklets provide patients with essential knowledge and tools to actively manage their condition9. These materials dispel misconceptions about low back pain, encouraging patients to adopt beneficial behaviours such as staying active and avoiding prolonged bed rest10. By fostering self-management and coping strategies, health education empowers individuals to take control of their recovery, leading to improved outcomes and reduced reliance on healthcare services11. Vitamin D supplementation offers another critical component, addressing biochemical deficits that exacerbate musculoskeletal dysfunction and chronic pain12. Vitamin D deficiency, a widespread issue even in sun-rich regions, contributes to oxidative stress, mitochondrial dysfunction, and central neuronal hypersensitivity, all of which can worsen pain and hinder physical rehabilitation13. By optimizing vitamin D levels, supplementation enhances muscle function and reduces the neurological factors associated with chronic pain, creating a supportive biochemical environment for recovery12.
CLBP remains a significant public health challenge, with limited evidence comparing multidisciplinary interventions targeting both educational and biochemical factors. While therapeutic exercises are widely recognized for their efficacy, the combined impact of health education and vitamin D3 supplementation on pain intensity, functional disability, and biochemical outcomes is not well understood. This study hypothesizes that in conjunction with therapeutic exercises, health education and self-awareness booklets will show comparable or superior effects on managing CLBP compared to vitamin D3 supplementation with exercises. The primary aim of this study was to evaluate the effectiveness of these interventions in improving pain intensity, serum vitamin D3 levels, and functional disability.
Material and Methods
Study design and settings
This randomised clinical trial employed an assessor-blinded, multi-centre, two-arm parallel research design from January 2023 to April 2023 in the Centre for the Rehabilitation of the Paralysed (CRP) and the Saic College of Medical Science and Technology (SCMST), Dhaka, Bangladesh. The Centre for the Rehabilitation of the Paralysed (CRP) is a not-for-profit organization offering comprehensive rehabilitation services, including physiotherapy, occupational therapy, and vocational training. It specializes in spinal cord injury management but is also renowned for its quality services for chronic low back pain patients and serves a large patient population, with approximately 129,471 patients treated annually. In contrast, the Saic College of Medical Science and Technology (SCMST) is a private, for-profit institution focusing on medical education and clinical training in physiotherapy, occupational therapy, and diagnostic sciences. While SCMST primarily functions as an academic centre, it provides healthcare services through affiliated hospitals and clinics, contributing to the clinical skill development of healthcare professionals in Bangladesh14,15.
Participant recruitment and diagnosis of CLBP
Individuals with CLBP were recruited for this study between January and April 2023 from the Outpatient Service Unit, Department of Physiotherapy, CRP, and SCMST in Dhaka, Bangladesh. Eligible participants had experienced CLBP for over 3 months, classified as central pain according to ICD-10-CM Code M54.5 criteria13, were 18 years or older, residing in or near Dhaka city, and employed in office, industrial, or corporate settings involving static postures or desk jobs requiring at least 6 hours of sitting daily9. Exclusion criteria encompassed the presence of comorbidities, such as rheumatoid arthritis, ankylosing spondylitis, osteomalacia, or spinal tuberculosis, as well as any history of osteoporotic fractures12; post-menopausal women or females over the age of 50 were excluded, along with individuals reporting recent intake of calcium or vitamin D3 supplements, regular engagement in resistance training, or high-impact weight-bearing activities within the past 6 months; additionally, patients presenting dural signs, a positive straight-leg raise test, or bowel and bladder incontinence were not included in the study.
In this study, CLBP was diagnosed based on pain persisting for more than 3 months, following a systematic clinical protocol. This included a detailed patient history assessing pain duration, intensity, location, associated symptoms (e.g., numbness or radiculopathy), and psychosocial factors such as stress or depression.
A physical examination was conducted to evaluate musculoskeletal and neurological involvement, including tests such as the straight leg raise16,17. Diagnostic imaging (e.g., X-ray or MRI) was used selectively in cases presenting with red flags or when symptoms persisted despite initial conservative management, in line with the American College of Physicians’ guidelines recommending clinical evaluation over routine imaging18,19.
Randomization and blinding
Eligible participants were referred to the musculoskeletal units of the Department of Physiotherapy, CRP, and SCMST for further screening with a concealed random allocation after the screening process. Before commencing the intervention, there was a separate cubicle for the blinded assessors to complete the informed consent and baseline assessment of both Group A and B participants. After the end of the treatment protocol, each participant re-entered the same room for outcome evaluation. A computerised random allocation technique using Microsoft Excel 2013 was used to assign the participants to the groups.
Sample size calculation
The sample size was calculated using statistical power analysis, facilitated by the PASS 2005 software (NCSS, Kaysville, UT, USA). To detect a statistically significant difference with a power of 90% and a two-sided alpha level of 0.05, a minimum of 38 participants per group was needed. To account for a potential 20% dropout rate, the sample size was increased to 42 participants per group (total n=84), preserving the study’s intended statistical power. The power calculation was based on expected changes in the primary outcome measure and pain intensity, as observed in prior studies of chronic musculoskeletal conditions20,21.
Intervention
Group A interventions
Group A participants received a study-specific therapeutic exercise program set by the trial investigators with a health education and self-awareness booklet.
- Health education and self-awareness booklet: A booklet consisting of different health education and self-awareness tips like avoiding long-term static sitting and standing; taking naturally vitamin D3-containing foods like milk, cereal, orange juice, yogurt, mushrooms, margarine, hard-boiled eggs, sea fish like tuna, salmon, etc.; 60 minutes of sun exposure from 11 am to 2 pm daily, 7–8 hours of sleep per night, avoid stress, avoid, smoking, and maintain a healthy body weight22.
- Specific therapeutic exercise program: The specific therapeutic exercise protocol consists of the McKenzie’s Mechanical Diagnosis and Therapy (MDT) Method, including directional preference, sustained positioning, flexion, or the extension principle (most often need extension principle) with a set of 10 repetitions23; stretching exercises of the erector spine muscle, hamstring, and triceps surae; lumbar stabilization exercises; weight-bearing aerobics exercise includes jogging, jogging with stair climbing, and 30 minutes of brisk walking and heating modalities (i.e., Infra Red Radiation)24.
Group B interventions
Group B participants also received the same specific therapeutic exercise program intended for Group A, but also with 40,000 IU vitamin D3 supplement capsules25prescribed by a registered physician, to be taken once a week for 8 weeks.
Both groups followed a structured therapeutic exercise protocol, with each session lasting up to 45 minutes, conducted 3 times per week over a period of 8 weeks.
Outcome Measurements
Brief Pain Inventory (BPI)
The Brief Pain Inventory (BPI) is a fifteen-item tool designed to assess pain severity and its impact on daily functioning. It evaluates how pain interferes with relationships, emotional well-being, quality of life, and physical activities such as sleep, general activity, and walking. The inventory also includes pain diagrams and queries about medication use, including analgesics. Higher scores indicate greater pain severity and interference16,26. The BPI demonstrates excellent internal consistency (Cronbach’s alpha=0.91), strong interrater reliability (ICC=0.84–0.90), and robust test-retest reliability with kappa values exceeding 0.7017,27.
Measurement of vitamin D levels
Following the pre-treatment assessment, blood samples were obtained from all participants at the clinic’s laboratory. Serum levels of 25-hydroxyvitamin D2 and D3 were analysed using the Elecsys Vitamin D Total II assay (Roche Diagnostics)28, a method closely correlated with the reference standard of liquid chromatography–tandem mass spectrometry. Vitamin D levels were subsequently classified into 3 categories: inadequate (<20 ng/mL), insufficient (20–29.9 ng/mL), and sufficient (>30 ng/mL)29,30.
Ronald Morris Disability Questionnaire (RMDQ)
The Roland-Morris Questionnaire (RMQ) is a 24-item, patient-reported tool designed to assess pain-related functional impairment caused by lower back pain (LBP)31. Each item is scored as 0 if left blank or 1 if selected, resulting in a total score ranging from 0 to 24, where higher scores indicate greater impairment. The questionnaire demonstrates absolute reliability (SEM: 1.7–2.0 points) and strong test-retest reliability, with intra-class correlation coefficients ranging from 0.79 to 0.8832.
Data analysis
Statistical analyses were conducted using IBM SPSS Version 25. Data normality was assessed via the Kolmogorov-Smirnov test, which indicated non-normal distribution (p-value<0.05). Accordingly, descriptive statistics were reported as medians and interquartile ranges (IQR) for sociodemographic variables. Parametric tests were applied to interval or ratio data, while non-parametric tests were used for nominal or ordinal data. Baseline differences in continuous variables between groups were analyzed using the Mann-Whitney U test. Categorical and ordinal variables were assessed using Fisher’s exact test and Pearson’s Chi-square test, respectively. Between-group comparisons of pain intensity, serum vitamin D3 levels, and functional disability were performed using the Mann-Whitney U test, while within-group changes were evaluated using the Wilcoxon signed-rank test. Statistical significance was set at p-value<0.05.
Ethical issues and informed consent
The study received approval from the CRP Ethical Review Committee (ERC) of the Centre for the Rehabilitation of the Paralysed (CRP), Savar, Dhaka-1343 (CRP-R&E-0401-0412), and the Saic College of Medical Science and Technology (SCMST), Mirpur-14, Dhaka-1216 (SCMST/IRB/25-11/12-002), Bangladesh. Written informed consent was obtained from all participants and their legal guardians. All procedures adhered to the relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki.
Results
A total of 101 individuals with chronic low back pain (CLBP) were screened, with 17 excluded due to not meeting the inclusion criteria or unwillingness to participate. Consequently, 84 eligible patients were enrolled in the trial, with no dropouts during the intervention. The Consolidated Standards of Reporting Trials (CONSORT) was followed to conduct this study and is supplied as Figure 1.
Figure 1 Consolidated standards of reporting trials (CONSORT) of the study
Demographic and clinical characteristics
The demographics and clinical characteristics of the participants are summarized in Table 1. The average age was 37.50 years (IQR: 27 to 55). Of the total participants, 23 (27.4%) were female, while 61 (72.6%) were male. Nearly half (n=40; 47.6%) resided in rural areas, with 42 (50.0%) having secondary or higher education. A substantial proportion (41; 48.8%) had no formal employment. Regarding clinical parameters, only 7 (8.3%) engaged in daily exercise, while 17 (20.2%) had at least 2 hours of sun exposure daily. A minimal number (n=6; 7.1%) reported a habit of daily milk consumption. These characteristics did not show any statistically significant differences between the groups (p-value>0.05).
Table 1 Demographic and clinical characteristics of the participants
| Variables | Group A (n=42) | Group B (n=42) | p-value |
|---|---|---|---|
| Demographic characteristics | |||
| Age in years [median (IQR)]a | 43 (29.50 to 55) | 38 (25 to 56.25) | 0.91* |
| Sex [% (n)]b | |||
| Male | 73.8 (31) | 71.4 (30) | 0.33 |
| Female | 26.2 (11) | 28.6 (12) | |
| Education [% (n)]c | |||
| Primary education | 40.5 (17) | 26.2 (11) | 0.41 |
| Completed SSC & HSC | 42.9 (18) | 57.1 (24) | |
| Bachelor and above degree | 16.7 (7) | 16.7 (7) | |
| Living area [% (n)]c | |||
| Urban | 31.0 (13) | 28.6 (12) | 0.09 |
| Rural | 50.0 (21) | 45.2 (19) | |
| Semi-urban | 19.0 (8) | 26.2 (11) | |
| Occupation [% (n)]c | |||
| No formal job/Unemployed | 59.5 (25) | 38.1 (16) | 0.72 |
| Student | 14.3 (6) | 40.5 (17) | |
| Service holder | 26.2 (11) | 21.4 (9) | |
| Clinical characteristics | |||
| Exercise habit [% (n)]b | |||
| Yes | 7.1 (3) | 9.5 (4) | 0.51 |
| No | 92.9 (39) | 90.5 (38) | |
| Sun exposure [% (n)]b | |||
| Less than 2 hours/daily | 19.0 (8) | 21.4 (9) | 0.56 |
| More than 2 hours/daily | 81.0 (34) | 78.6 (33) | |
| Milk consumption [% (n)]b | |||
| Yes | 11.9 (5) | 2.4 (1) | 0.75 |
| No | 88.1 (37) | 97.6 (41) | |
| Chronic illness [% (n)]c | |||
| Diabetic Mellitus | 40.5 (17) | 26.2 (11) | 0.46 |
| Hypertension | 42.9 (18) | 57.1 (24) | |
| Heart disease | 16.7 (7) | 16.7 (7) | |
| Body mass index [median (IQR)]a | 23.9 (20.6 to 26.7) | 24.4 (19.9 to 27.2) | 0.64 |
| Brief Pain Inventory (BPI) [median (IQR)]a | |||
| Pain severity score | 5.3 (4.8 to 5.5) | 5.3 (4.8 to 5.8) | 0.84 |
| Affective score | 5.4 (4.6 to 6) | 5.4 (4.3 to 6) | 0.76 |
| Activity score | 5.7 (4.7 to 6) | 5.2 (5 to 5.7) | 0.31 |
| Vitamin D3 Level (ng/mL) [median (IQR)]a | 17.4 (15.8 to 19.4) | 17.0 (15.8 to 19.2) | 0.67 |
| Ronald Morris Disability Questionnaire (RMDQ) [median (IQR)]a | 8 (5 to 12) | 8.5 (5.8 to 12.3) | 0.95 |
*baseline compatible, aMann-Whitney U test, bFisher exact test, cPearson Chi-square test, IQR=inter quartile range, SSC=secondary school certificate, HSC=higher secondary certificate
Brief Pain Inventory
Table 2 compares pain and activity outcomes for two groups (A and B) before and after treatment, measuring Pain Severity, Affective, and Activity Scores. Each group’s baseline and post-treatment median scores (with IQR) are presented, alongside within-group (p-value=0.01) and between-group (p-value=0.01) change scores. Both groups showed significant improvements (p-value<0.01) post-treatment, but Group B consistently achieved lower median scores, indicating a greater treatment efficacy, with statistically significant differences favoring Group B across all measures (p-value<0.01).
Table 2 Baseline and after-treatment status of pain by Brief Pain Inventory Domains
| Outcome group | Baseline | After treatment | Within group change scores | Between group change scores | ||
|---|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Z | p | Z | p | |
| Pain severity score | ||||||
| Group A | 5.3 (4.8 to 5.5) | 4.2 (3.3 to 5.2) | 5.544 | 0.001* | 6.052 | 0.0001* |
| Group B | 5.3 (4.8 to 5.8) | 2.5 (1.4 to 3.7) | 5.047 | 0.001* | ||
| Pain affective score | ||||||
| Group A | 5.4 (4.6 to 6) | 4.9 (3.3 to 5.9) | 5.489 | 0.001* | 6.518 | 0.0001* |
| Group B | 5.4 (4.3 to 6) | 3.4 (2.4 to 4.3) | 5.358 | 0.001* | ||
| Activity score | ||||||
| Group A | 5.7 (4.7 to 6) | 4.5 (3.1 to 5.7) | 5.542 | 0.001* | 4.990 | 0.0001* |
| Group B | 5.2 (5 to 6.7) | 2.1 (2.1 to 4.9) | 5.256 | 0.001* | ||
*significant at 95% confidence level, within-group analysis: wilcoxon rank test, between-group analysis: Mann-Whitney U test, IQR=inter quartile range
Vitamin D3 level measurement
Figure 2 compares vitamin D3 levels (in ng/mL) for Group A (blue) and Group B (purple) at baseline and after the intervention. At baseline, Group A had a level of 17.4 ng/mL, and Group B was slightly lower at 17 ng/mL. After the intervention, Group A’s level increased to 31.5 ng/mL, while Group B’s level increased more significantly to 39.1 ng/mL. The chart visually highlights that both groups experienced an increase in vitamin D3 levels post-intervention, with Group B showing a significantly greater improvement (p-value<0.01).
Figure 2 Differences in vitamin D3 levels across both groups
Ronald Morris Disability Questionnaire (RMDQ)
Table 3 compares outcomes on the Ronald Morris Disability Questionnaire (RMDQ) for two groups (A and B) before and after treatment. At baseline, both groups had similar medians (Group A: 8, Group B: 8.5). Post-treatment, Group A’s median dropped to 4.5 and Group B’s to 3, with significant within-group improvements (p-value=0.03 for Group A, p-value=0.01 for Group B). The between-group change was significant (p-value<0.01), indicating that Group B showed a greater reduction in disability scores.
Table 3 Baseline and after-treatment status of back pain induced disability by Ronald Morris Disability Questionnaire (RMDQ)
| Outcome group | Baseline | After treatment | Within group change scores | Between group change scores | ||
|---|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Z | p | Z | p | |
| Ronald Morris Disability Questionnaire (RMDQ) | ||||||
| Group A | 8 (5 to 12) | 4.5 (3.8 to 7) | 2.820 | 0.03* | 7.648 | 0.01* |
| Group B | 8.5 (5.8 to 12.3) | 3 (2 to 4) | 5.519 | 0.01* | ||
*significant at 95% confidence level, within-group analysis: wilcoxon rank test, between-group analysis: Mann-Whitney U test, IQR=inter quartile range
Discussion
This study compared two multidisciplinary interventions for CLBP: therapeutic exercises combined with either health education (Group A) or vitamin D3 supplementation (Group B). Both groups showed significant improvements in pain intensity, serum vitamin D levels, and functional disability. However, Group B exhibited greater reductions in pain severity, affective and activity interference, and disability scores, alongside a more substantial increase in serum vitamin D3 (39.1 ng/mL).
This study found that both intervention groups, therapeutic exercises combined with health education (Group A) and with vitamin D3 supplementation (Group B), achieved statistically significant reductions in pain severity, affective interference, and activity limitation scores. Notably, Group B consistently demonstrated greater improvements, with lower post-treatment median pain scores and significant between-group differences favoring vitamin D3 supplementation (p-value<0.01). These results align with findings from a 2016 meta-analysis by Wu et al.33, which reported a modest but statistically significant reduction in pain scores among individuals receiving vitamin D3 supplementation compared to placebo (mean difference −0.57, 95% CI: −1.00 to −0.15, p-value=0.01), suggesting that correcting vitamin D3 deficiency may enhance pain relief in chronic musculoskeletal conditions.
The increase in vitamin D3 levels in this study contrasts with some existing literature. Ghai et al.34found no significant association between vitamin D deficiency and chronic pain in certain cohorts, suggesting that the observed benefits might be intervention-specific or population-dependent. The post-intervention levels exceeding the 30 ng/mL threshold recommended for optimal musculoskeletal health by Hernigou et al.35align with the systematic review and meta-analysis by de Souza et al.36, which demonstrated improved functional outcomes with vitamin D supplementation in elderly populations. The differential response between Group A and Group B could indicate that the intervention’s efficacy is amplified by achieving or surpassing this threshold, particularly in Group B, where the 39.1 ng/mL level suggests a robust metabolic or therapeutic response.
Comparatively, the RMDQ reductions observed align with prior research validating its sensitivity to change in chronic low back pain populations. Sung and Wu37 established a minimal detectable change of 2.5-5 points, which is consistent with the drops from 8 to 4.5 in Group A and 8.5 to 3 in Group B, indicating clinically meaningful improvements. The greater reduction in Group B’s scores suggests a stronger therapeutic effect, potentially tied to the higher vitamin D3 levels, a hypothesis supported by Alonso-Pérez et al.12, who reported a correlation between elevated vitamin D status and reduced musculoskeletal pain.
Conclusion
This study shows significant improvements in pain and disability across both groups, with greater reductions in the group achieving higher vitamin D levels. The results underscore the treatment’s effectiveness and suggest that optimizing vitamin D may enhance therapeutic outcomes. These findings align with existing evidence supporting vitamin D’s role in pain management. Future research should employ randomized, standardized trials with broader metrics to validate and generalize these results.
Trial registration
Clinical Trials Registry India (CTRI/2022/11/047074).
Acknowledgement
We sincerely thank all the participants for their valuable and voluntary contributions.
Funding sources
This was a self-funded study, and the authors did not receive any external funding.
Conflict of interest
This study was funded by the University Grant Commission through Jashore University of Science and Technology, Jashore - 7408, Bangladesh. Grant No.: 24-FoAST-11.
References
- Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health; potential mechanisms. Nutrients 2010;2:693–724.
- Paradzik Simunovic M, Degoricija M, Stanic R, Terzic J, Simunovic M. The Potential Role of Vitamin D in the Pterygium Pathophysiology—A Possible New Therapeutic Perspective and Narrative Review. J Clin Med 2025;14:3640.
- Pascual A, Aranda A. Thyroid hormone receptors, cell growth and differentiation. Biochim Biophys Acta 2013;1830:3908-16.
- Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants. Front Nutr 2023;10:1070808.
- De Sario M, de’Donato FK, Bonafede M, Marinaccio A, Levi M, Ariani F, et al. Occupational heat stress, heat-related effects and the related social and economic loss: a scoping literature review. Front Public Health 2023;11:1173553.
- Alyahya KO. Poor dietary consumption and limited sun exposure are risk factors for vitamin D deficiency in premenopausal Kuwaiti women: a cross-sectional study. Qatar Med J 2020;2020:15.
- Ghai B, Bansal D, Kanukula R, Gudala K, Sachdeva N, Dhatt SS, et al. Vitamin D supplementation in patients with chronic low back pain: an open label, single arm clinical trial. Pain Physician 2017;20:E99-105.
- Lewis R, Gómez Álvarez CB, Rayman M, Lanham-New S, Woolf A, Mobasheri A. Strategies for optimising musculoskeletal health in the 21 st century. BMC Musculoskelet Disord 2019;20:164.
- Gordon R, Bloxham S. A systematic review of the effects of exercise and physical activity on non-specific chronic low back pain. Healthcare (Basel) 2016;4:22.
- Kripa S, Kadiresan M. Low back pain myths: a narrative review. Bull Fac Phys Ther 2024;29:62.
- Petersson C, Nygårdh A, Hedberg B. To support self-management for people with long-term conditions–The effect on shared decision-making, empowerment and coping after participating in group-learning sessions. Nurs Open 2022;9:2444–53.
- Alonso-Pérez JL, Martínez-Pérez I, Romero-Morales C, Abuín-Porras V, López-Bueno R, Rossettini G, et al. Relationship between serum vitamin D Levels and chronic musculoskeletal pain in adults: a systematic review. Nutrients 2024;16:4061.
- Habib AM, Nagi K, Thillaiappan NB, Sukumaran V, Akhtar S. Vitamin D and its potential interplay with pain signaling pathways. Front Immunol 2020;11:820.
- Centre for the Rehabilitation of the Paralysed (CRP). Physiotherapy Department [homepage on the Internet]. Bangladesh: CRP; [cited 2025 Jun 9]. Available from: https://crp-bangladesh.org/Services/therapy/physiotherapy-dept
- Saic College of Medical Science and Technology (SCMST). Physiotherapy Department [homepage on the Internet]. Bangladesh: SCMST; [cited 2025 Jun 9]. Available from: https://scmst.ac.bd/physiotherapy
- Hochheim M, Ramm P, Wunderlich M, Amelung V. A cross-sectional study to validate an administrative back pain severity classification tool based on the graded chronic pain scale. Sci Rep 2022;12:16927.
- Kibria MG, Parvez MS, Saha P, Talapatra S. Evaluating the ergonomic deficiencies in computer workstations and investigating their correlation with reported musculoskeletal disorders and visual symptoms among computer users in Bangladeshi university. Heliyon 2023;9:e22179.
- Nicol V, Verdaguer C, Daste C, Bisseriex H, Lapeyre É, Lefèvre-Colau MM, et al. Chronic low back pain: a narrative review of recent international guidelines for diagnosis and conservative treatment. J Clin Med 2023;12:1685.
- Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, et al. Report of the NIH Task Force on research standards for chronic low back pain. J Pain 2014;15:569-85.
- Sattar MM, Khan AH, Kabir MF, Hossain KA, Jahan S, Rahman E, et al. Effectiveness of massage gun versus myofascial release technique for releasing latent trigger points of the calf muscle: a protocol for randomized clinical trial. Physiother Res Int 2025;30:e70055.
- Khan AH, Bhuiyan MS, Kabir MF, Hossain MZ, Jahan S, Hossain KA, et al. Effectiveness of proprioceptive neuromuscular facilitation pattern on upper extremity and scapula in patients with adhesive capsulitis: a single-centre assessor-blinded randomised controlled trial (RCT). Trials 2025;26:146.
- Tawa N, Rhoda A, Diener I. Accuracy of clinical neurological examination in diagnosing lumbo-sacral radiculopathy: a systematic literature review. BMC Musculoskelet Disord 2017;18:93.
- Wáng YX, Wu AM, Santiago FR, Nogueira-Barbosa MH. Informed appropriate imaging for low back pain management: a narrative review. J Orthop Translat 2018;15:21-34.
- Hossain MA, Jahid IK, Hossain MF, Uddin Z, Kabir MF, Hossain KM, et al. Efficacy of McKenzie manipulative therapy on pain, functional activity and disability for lumbar disc herniation. Open Sports Sci J 2021;14:14-24.
- Qaseem A, Wilt TJ, McLean RM, Forciea MA, Clinical Guidelines Committee of the American College of Physicians*. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017;166:514-30.
- Jelsness-Jørgensen LP, Moum B, Grimstad T, Jahnsen J, Opheim R, Prytz Berset I, et al. Validity, reliability, and responsiveness of the brief pain inventory in inflammatory bowel disease. Can J Gastroenterol Hepatol 2016;2016:5624261.
- Jumbo SU, MacDermid JC, Kalu ME, Packham TL, Athwal GS, Faber KJ. Measurement properties of the Brief Pain Inventory-Short Form (BPI-SF) and Revised Short McGill Pain Questionnaire Version-2 (SF-MPQ-2) in pain-related musculoskeletal conditions: a systematic review. Clin J Pain 2021;37:454-74.
- Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73-8.
- Mirza F, Canalis E. Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015;173:R131-51.
- Zouine N, Lhilali I, Menouni A, Godderis L, El Midaoui A, El Jaafari S, et al. Development and validation of vitamin D-food frequency questionnaire for Moroccan women of reproductive age: use of the sun exposure score and the method of triad’s model. Nutrients 2023;15:796.
- Stratford PW, Riddle DL. A Roland Morris Disability Questionnaire target value to distinguish between functional and dysfunctional states in people with low back pain. Physiother Can 2016;68:29-35.
- Traub ML, Finnell JS, Bhandiwad A, Oberg E, Suhaila L, Bradley R. Impact of vitamin D3 dietary supplement matrix on clinical response. J Clin Endocrinol Metab 2014;99:2720–8.
- Wu Z, Malihi Z, Stewart AW, Lawes C, Scragg R. Effect of vitamin D supplementation on pain: a systematic review and meta-analysis. Pain Physician 2016;19:415.
- Ghai B, Bansal D, Kapil G, Kanukula R, Lavudiya S, Pharm M, et al. High prevalence of hypovitaminosis D in Indian chronic low back patients. Pain Physician 2015;18:E853-62.
- Hernigou P, Sitbon J, Dubory A, Auregan JC. Vitamin D history part III: the “modern times”—new questions for orthopaedic practice: deficiency, cell therapy, osteomalacia, fractures, supplementation, infections. Int Orthop 2019;43:1755-71.
- de Souza MD, Moraes Dantas RL, Leão Durães V, Defante ML, Mendes TB. Vitamin D supplementation and the incidence of fractures in the elderly healthy population: a meta-analysis of randomized controlled trials. J Gen Intern Med 2024;39:2829-36.
- Sung YT, Wu JS. The visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods 2018;50:1694-715.
J Health Sci Med Res 2026;44(5):e20261328 · www.jhsmr.org
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.